EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fertility preservation and in vitro fertilization (IVF) success rates after cancer

Chelsea Anderson iD, Alexis C Wardell iD, Allison M Deal iD, Jennifer E Mersereau, Katie Cameron iD, Steven D Spandorfer, Valerie L Baker iD, Sara Mitra iD, Jianwen Cai iD, Barbara Luke iD, Hazel B Nichols iD

JNCI Cancer Spectrum · 2025

DOI: 10.1093/jncics/pkaf057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2025. Verfasst von Chelsea Anderson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States. Hauptthemen laut MEDLINE: Fertilization in Vitro, Fertility Preservation, Neoplasms, Oocyte Retrieval. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence of the success of in vitro fertilization (IVF) procedures is critical for informed decision making before and after cancer treatment. We compared IVF outcomes between women with and without cancer.

Methods

Using data from a national IVF database—the Society for Assisted Reproductive Clinic Outcomes Reporting System, linked to statewide cancer registries and birth certificates in 9 states—we identified women who initiated IVF after a cancer diagnosis. Fertility preservation was defined as oocyte retrieval ≤90 days after cancer diagnosis, and IVF after cancer treatment as retrieval >90 days postdiagnosis. Number of oocytes retrieved and conception and livebirth rates were compared between these groups and a comparison group of women without cancer in couples with male factor infertility only.

Results

Compared with retrievals for male factor infertility only (n = 81 370), the number of oocytes retrieved was not significantly different for women who underwent retrieval for fertility preservation (n = 2941) but was significantly lower for women who underwent retrievals after cancer treatment (n = 2479) (mean difference = −2.99, 95% confidence interval [CI] = −3.40 to 2.59). Rate of conception as a function of transfer attempts and likelihood of livebirth after conception also did not significantly differ for fertility preservation (n = 291) compared with male factor infertility only (n = 34 410). Women with IVF after cancer treatment (n = 672) had a lower rate of conception (hazard ratio = 0.70, 95% CI = 0.61 to 0.79) but a similar overall likelihood of a livebirth after conception, relative to the group with male factor infertility only.

Conclusion

IVF outcomes may be maximized when ovarian retrieval is initiated before cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertilization in VitroFertility PreservationNeoplasmsOocyte RetrievalHumansFemaleAdultMalePregnancyLive BirthInfertility, MalePregnancy Rate

Autor:innen und Institutionen

  • Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
  • Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Shady Grove Fertility, Carolinas, Cary, NC, United States.
  • Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • The Center for Reproductive Medicine and Infertility, Cornell University Medical Center, New York, NY, United States.
  • Department of Biostatistics, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, United States.

ORCID-Profile: Chelsea Anderson, Alexis C Wardell, Allison M Deal, Katie Cameron, Valerie L Baker, Sara Mitra, Jianwen Cai, Barbara Luke, Hazel B Nichols

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Anderson, C., Wardell, A. C., Deal, A. M., Mersereau, J. E., Cameron, K., Spandorfer, S. D., Baker, V. L., Mitra, S., Cai, J., Luke, B., & Nichols, H. B. (2025). Fertility preservation and in vitro fertilization (IVF) success rates after cancer. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkaf057

Vancouver

Anderson C, Wardell AC, Deal AM, Mersereau JE, Cameron K, Spandorfer SD, et al. Fertility preservation and in vitro fertilization (IVF) success rates after cancer. JNCI Cancer Spectrum. 2025. doi:10.1093/jncics/pkaf057

BibTeX
@article{Anderson2025,
  author = {Anderson, Chelsea and Wardell, Alexis C and Deal, Allison M and Mersereau, Jennifer E and Cameron, Katie and Spandorfer, Steven D and Baker, Valerie L and Mitra, Sara and Cai, Jianwen and Luke, Barbara and Nichols, Hazel B},
  title = {Fertility preservation and in vitro fertilization (IVF) success rates after cancer},
  journal = {JNCI Cancer Spectrum},
  year = {2025},
  doi = {10.1093/jncics/pkaf057}
}
Kostenlos starten →